The presentation will focus on summarizing our understanding of the contribution of heritable factors to prostate cancer predisposition and the difficulties researchers have faced in identifying susceptibility genes impacting this common cancer. There have been statements from NCCN and other societies recommending genetic testing for unaffected men presumed to be at high risk for the disease as well as for men with metastatic prostate cancer. Because prostate cancer is such a common disease, this has created significant challenges for providers and patients.
Level of Instruction: Intermediate